US 10730948
Methods for treating eosinophilic esophagitis by administering an IL-4R inhibitor
granted A61KA61K2039/505A61K2039/54
Quick answer
US patent 10730948 (Methods for treating eosinophilic esophagitis by administering an IL-4R inhibitor) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Aug 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2039/505, A61K2039/54, A61K2039/545, A61K2039/577